SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676744
Filing Date
2016-08-09
Accepted
2016-08-09 16:07:08
Documents
57
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d216887d10q.htm 10-Q 617146
2 EX-31.1 d216887dex311.htm EX-31.1 8227
3 EX-31.2 d216887dex312.htm EX-31.2 8213
4 EX-32.1 d216887dex321.htm EX-32.1 4247
11 GRAPHIC g216887g69a24.jpg GRAPHIC 133307
  Complete submission text file 0001193125-16-676744.txt   3389763

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT enta-20160630.xml EX-101.INS 529649
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20160630.xsd EX-101.SCH 33341
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20160630_cal.xml EX-101.CAL 62528
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20160630_def.xml EX-101.DEF 140483
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20160630_lab.xml EX-101.LAB 311810
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20160630_pre.xml EX-101.PRE 233521
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 161817931
SIC: 2834 Pharmaceutical Preparations